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higher dsk for a worse early and mid term clinical evolution as wall as mid 
term LVEF changes after AML This data may stimulate further research to 
fully define MRI role in larger trials. 
~'~'---9~ Multisllca Resonance Imaging of  Magnetic 
Myocardial Perfusion Using Gd-HP-OO3A on e 
Conventional  Clinical Scanner: A Comi~r~son Study 
With Radlonuclide Perfuslon Imaging in a General 
Patient Population 
Edward G. Walsh, Mark A. Lawson, Mark Doyle, Gerald M. Pohost. 
Unh, ersity of Alabama at Birmingham, Deparfmant of Medicine, Division of 
Cardiovascular Disease, Birmingham AL 
We have compared the results of first-pass magnetic r~onanco Imaging of 
myocardial perfusion using the contrast agent Gd-HP-DO3A (Bracco, Spa.) 
to those obtained from radionuclide imaging in a population of 63 patients 
referred for perfusion studies owing to known or suspected CAD. Short axis 
MR perfuslon images were acquired at 3 or 4 tomographic levels with heart- 
boat or alternate heartbeat temporal resolution dudng the first pass of a 
bolus of Gd-HP-DO3A (0.08 to 0.1 retool/ks) administered using a proto- 
type power injector (Modred, Inc.) over 2-3 s. MR perfusion images ware 
acquired under dipyddamole (0.56 ms/ks) vasoditaiion conditions along with 
administration of 99m-Tc-sestamibi. Patients also received 201-1"1 resting 
radionuclide scans on the same day as their MR perfusion images. 
For analysis, short axis representctions were divided into six regions cor- 
responding to anterior, anterotateral, Inleml.~teral, inferior, inferoseptum and 
anteroeeptum. A total of 1355 regions were compared. MR image perfu. 
slon defects were defined as greater than 1.5sd reduction in slope of the 
time/intensity cuwe (typically corresponding to a 20% reduction In slope 
compared to normal tissue). Comparison between MR and radionuclide ira- 
ages resulted in a sensitivity of 71% with a specificity of 96°/o. Sensitivity is 
known to be affected by reduced dependence on viability in the distribution of 
Gd-HP-DO3A (an extrevascular agent) which results in some false negative 
comparisons when compared to radionucilde distribution. 
~"6---'~0"1 Myocardial  Firat Pass imaging MS-325, a With New 
Intmvascular Magnetic Resonance Contrast Agent 
Robert P. Dolan I Poftumarthi V. Prosed, Plotr A. Wielopolski, Wei Li, 
Richard C. Wefovitch 1, Robert R. Edalman, Randall B. Laulfar 1.1 Metasys, 
Inc., Cambridge, MA; Department of Radiology, Beth Israel Hospital, 
Boston, MA 
We have compared the first pass myocardial enhancement profile of MS-325, 
an MR anglographic imaging agent, to that of a non-clinical intravascular 
agent (Gd-OTPA-labeled bovine serum albumin [Gd-DTPA-BSA]) and to the 
clinical extracollular agent Gd-DTPA. MS-325 is a novel small-motecole Gd 
chelate which binds reversibly to albumin (90-95%). Gated dynamic IR 
Turbo-FLASH Imaging of 4 pigs was performed after ear vein bolus injection 
(2 sac) of the agents at doses which produce equivalent peak myocardial 
enhancement. As an indicator of degree of Intravascular distribution, the 
following ratio was calculated during the first pass time Interval: 
~=o.,~ M,~-325 5 pmol/kO '1C-d.DTPA-BSA 5 pmol/ko 1 Gd-DTPA 25 l, mlol/k s 
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The first pass myocardial enhancement profile of MS-325 was parabolic (R 
= 0.72:1:0.21 ) and matched that cf Gd-DTPA-BSA (R = 0.69 ± 0.3f ) (see flg- 
uro below), demonstrating confinement of MS-325 to the Intravascular space. 
In contrast, due to added enhancement (app. 50%) from rapid extravasstion, 
Ihe Gd-DTPA profile was broadened and failed to return to baseline (R - 0.15 
4- 0.05, significantly less than MS-325 and Gd-DTPA-BSA, p < 0.01). 
In conclusion, MS-325 may enable better clinical estimation of regional 
myocardial blood volume than currenfly approved MR contrast agents. 
~ Regional Myocardial Perfusion by Ultrafest 
Magnetic Resonance Imaging In an F.xpedmental 
Animal Model 
Masslmo Lombardi, Richard A. Jones, Jorgsn Wasthy, Jam Kv~emsss, 
Galr To~peim, Antonio UAbbats, Peter A. Rlnck. MR-Center, Ttondhe/m, 
Norway; Clinical Physiology Institute, Pica, Italy 
Aim of the study was to assess regional myocardial perfusion by Ultraiast MRI 
at 0.5T in conjunction with the intravenous Inlecflon of a bolus of Gedopen- 
tstate (Gd-DTPA) in open chest pigs. Different levels of coronary blood flow 
wero generated in 9 animals by adenosine infusion or by a mechanical oc- 
cludar on the proximal eft anterior descending coronary arian/. Reference 
values of myocardial perfusfon were obtained by redidiabelled microspheres 
injected into the left atrium. 64 consecutive, alngta slice, ECG triggered, dl- 
astolic, short-axis images of the left ventricle were obtained while Gd-DTPA 
(0.05 retool/Ks) was injected. Peak intensity, time to peak, wash-in slope 
and class-correlation coefficient were computed from each lime-intensity 
curves, derived from 4 regions of interests (ROts) drawn on left vantricutar 
myocardlum. Values from the the Infedor wall ROI were used as reference to 
evaluate the relative differences of the remaining anterior, lateral and septal 
walls ROle. A total of 30 injections were performed within a coronary blood 
flow range of 0.005-1.9 ml/g/min. The cross conelation coefficient showed 
the best correlation with coronary blood flow (n = g0, r ,= 0.86, p < 0.001). 
Peak intensity (r = 0.72, p < 0.001) arid wash-in slope (r = 0,28, p < 0.06) 
also correlated with flow, whereas the time to peak did not (r = 0.04, p = 
ns). In conclusion, contrast enhanced uitrafast Magnetic Resonance allowed 
an accurate evaluation of regional myocardial perfusion heterogeneity in 
the experimental animal. The cress correlation coefficient resulted the most 
efficient parameter for the relative quaefitation of coronary blond flow. 
~ - ' ~  The Potentl=,l for  Determination of  Myocardial 
Viability Following Reperfueion With Gd-OTPA 
Enhanced MRI 
Gerald Wisenberg, Raoul S. Pereira, Frank S. Prate, Jane Sykes. Lawson 
Research Institute, University of Western Onta~o, London, Ontario, Canada 
This study was undertaken to determine the potential for MRI determination of 
infarct size/tissue viability at van/Ing time pednds post infarcttoru'raperfusion. 
In a canine model, the left anterior descending coronary artery was occluded 
for 2 hours, followed by reperfusfon for 2 hours (2 dogs), 4 hours (2 dogs), 1 
day (2 dogs), 1 week (8 dogs), 2 weeks (2 dogs), and 3 weeks (2 dogs). In 
each expedmant, he heart was excised I hour into a constant infusion of Gd- 
DTPA (bolus of 0,3 mmol/kg followed by 0.01 minor/kS/rain) for establishment 
of equilibdum of the contrast agent in tissue, and 30 minutes following 
intravenous thallium tntection (as a marker of tissue viability). From each 
heart, 70-130 samples were obtained for determination of microsphera blood 
flow, thallium uptake normalized to blond flow, and the distribution volume of 
Gd-DTPA (~.) which was defined as the [Gd-DTPA tissue]/[C-d-DTPA blood]. 
The correlation (r) between ~ and normalized thallium uptake, the slope of 
the regression line, and the values of ~. in the infarct and normal flow regions 
are demonstrated in the following table. 
Reperlusion r Slope ~. (infarct) flow < 0.4 X (normal) flow > 0.4 
period ml/mln/g ml/mtn/g 
2 hrs -0.83 -1.00 0.80-*- 0.17 0.21 4- 0.07 
4hrs -0.82 -1.07 0.94 4- 0.20 0.30 4- 0.04 
1 day -0.75 -1.02 0.934-0.13 0.39a-0.09 
1 week -0.75 -0.91 0.84 4. 0.26 0.24:1:0.10 
2 weeks -0.80 -1,80 0.764-0.15 0.25 ~ 0.06 
3 weeks -0.61 -0.83 0.52 ~ 0.15 0,28±0.08 
Therefore, up until and including 2 weeks following Infaretlon, the clinical 
determination of myocardial viability, through the absence of increases in ~. 
(Gd-DTPA enhancement on MRI imaging) may be feasible with MRI, as eady 
as 2 hours following reperfusion. 
~ - ~  Evalustlon of  O Wave and Non-O Wave Myocardial  
Infarction by Magnetic Resonance Imaging 
Ibralm Pinto, Ricardo Pavanello, Rnddgo Barrofto, Alexandre Ablzald, 
Leopoldo Piegas, Enilton Egito, Marcos Barbosa, Edson Romans, 
Amanda Souse, J. Eduardo Souse. Hospital do Cora~o, SDo Pau/o, Brazil 
Magnetic resonance imaging (MRI) can reveal the changes in the my- 
ocardium following an acute myocardial infarction (AMI). Its role in the eval- 
uation of pts with Q wave (Gmup-GI) AMI and with non-Q ((311) AMI is not 
reported yet. To assess its utility in this set we conducted a prospective anal- 
ysis of 79 pts with AMI tom February 92 to December 94. All lots undone'ant 
MRI and cardiac cathefedzalion (CC) before hospital discharge. MRI defined 
the myocardlum at risk as the areas with a high uptake of QDTPA-Gedefinlum 
(GADO), which was injected in all cases. Myocardial viability was defined as 
the ames with GADO washout < 30 rain. Them were 61 pts in GI and 18 tots 
in GII. Ejection fraction was 0.44 in GI and 0.49 in GII by MRI and 0.42 in GI 
and 0.50 in GII by CC, CC found 25 occluded AMI related artedes in GI and 3 
in GII. MRI showed a similar myocardium at dsk in both groups, but identified 
a larger area of early washout in Gfl (67% of the myocardlum at riak vs. 38% 
in Git). There was a subeplcardial area of early washout in 10 pts in GI and 
in 16 pts in GII. Four pts died In-hospital, all in GI. Another GI pt died after 
10 months, All pts who died had early GADO washout in < 40% of the MRI 
defined myocardlum at dsk. MRI was repeated in 56 pts of GI (all survivals) 
and in the 16 lOtS of GII. Gfobet ejection fraction was 0.44 in GI and 0.54 in 
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GII. All pts who Improved ejeslJon frastJon at folicw-up (28 in GI and 14 in GII) 
hed an early GADO washout in > 40% of the MRI defined myocard, Jm at 
dsk at baseline scan. The authors conclude that GADO enhanced MRI can 
effe,.'tively evaluate pts with Q wave and non-Q wave AMI, identifying pts at 
higher isk and predicting changes in global ejection fraction. This may give 
MRI a mere impartsnt role in the clinical investigation ofpts with AMI. 
~ Phase-conb'aat I~gnetic R~-qonan~ 
Angioglaphy: A New Approach in the Evaluation of 
Coronary LAD Artery Graft Patency and Flow 
Follswing Treatment of  LIMA Hypollerfusion 
Syndrome With Additional Vain Graft 
Gregor Zund, Markus Hauser, Paul Vogt, Jorg Oebatin, Ludwig K. von 
Segesser, Marko Turina. University Hospital, Zurich, Switzerland 
Pedoperative and early postoperative occlusion of a left internal mammary 
artew (LIMA) conduit may complicate myocardial revasculadzation leading 
to the potentially fatal LIMA hypoparfusion syndrome, Subsequent distal 
placement of a vein graft to the left anterior descending (LAD) artery may 
lead to concurrent or retrograde LIMA flow. The purpose of this study was 
to determine early and late postoperative flow rates in those patients who 
received LIMA and saphenous vein grafts to the LAD artery for treatment 
of LIMA hypoperfusion syndrome. Nineteen of twesty-ona patients who met 
this criteda were available for magnetic resonance imaging (MRI). Early (< 6 
months) and late (> 12 months} postoperative flow measurements of grafts 
were performed using conventional and a novel segment k-space phese- 
contrast MRI angiography technique. Early MRI controls revealed that all 
conduits had adapted to the coronary flow type with predominant diastolic 
perfusion. Patency rate at the eady and late control was 100%. Concurrent 
flow, flow reversal, or steal phenomena were absent. Mean flow rates were 
49.2 ml/mtn for the LiMA and 72.6 ml/min for the sephenous vein graft, 
respectively. Based on the Ilow data obtained with MRI angiography, the use 
of an additional sephenous vein graft as treatment of LIMA hypoparfusion 
syndrome does not lead to LIMA occlusion. Conduit flow adaptation to the 
diastolic predominance occurs in the first 6 months after operation. 
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~ Exercisc induced Ischemla in Myocardial 
Non-Obstructive Aneurysmatic Coronary Artery 
Disease Is Related to Coronary Diameters 
Dletrnar Kr0ger, Uldch Stiede, Abdolhamid Sheikhzadeh, 
Kad-Wemer Oladefich. Department of Cardiology, University LObeck, 
Germany 
Coronary aneurysms (CA) are defined as a dilatation of the coronary lumen 
> 1.5 fold of the normal diameter. CA are often associated with artsdoscta- 
rotic stenosis, the potency to cause a myocardial ischemia (C|) as a non- 
obstructive lesion with an impaired coronan] blood flow per se is discussed 
centroversialfy. 
Aim of the studywas to evaluate CI in patients (10is) with non-obstmative 
bilateral CA and to quantify its sevedty depending on the coronaly diameters. 
A coronary sinus lactate study with an incremental atrial pacing (CS) was 
performed in 31 pts, metabolic dteda for a CI were a reduction of the can:liac 
lactate extraction < l(P/o or a frank cardiac lactate production. Coronary 
angiographlas were screened for a segmental to and for movement and 
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Results: 21/31 pts with CA developed an exercise induced CI in CS with a 
high correlation of the coronary diameters and the severity of CI (p < 0.003, 
r = 0.87) as depicted below for the left antenor descending coronary artery. 
All pts with a pathological cardiac lactate metabolism fudhermore presented 
with marked angiographic signs of an impaired coronary blood flow (p < 
0.02). 
Conclusions: Non-obstructive CA were identified as an entity of ischemic 
coronanj adery disease due to an impaired coronary blond flow. A signifi- 
cant correlation between the coronary diameters and the severity of CI was 
revealed. 
r~7~ Intravenous L-Arginine Restores Vascular 
Rsectivity in the Conduit Arteries of Young 
Hypercholesterolemic Adults 
Peter Clarkson, Ronald Hemy, Ann Donald, Amanda Powe, Teresa Bull, 
John Doantield. Great Orrnond Street Hospital NHS Trust, London, UK 
Hypercholastemlemia (HC) is associated with endothelial dysfunction in the 
microvasculature ofbeth asymptomatic young adults and in those subjects 
with clinical evidence of atherosclerosis. This may be reversed by intravenous 
(IV) L-arginine (L-arg), but the effects on conduit artedas have not been ex- 
amined. We studied vascular eactivity in 6 HC subjects and 6 centrols (LOL- 
cholasteml 2.25 4- 0.62 mmol/I vs 4.76 4- 0.75 retool/I, p < 0.005), all of whom 
(age 29.6 4- 2.3 yrs; range 22-36) were asymptometic, non-smokers, non 
hypertensive, non diabetic and on no cardiovascular medication. Fwe of the 
HC subjects had Familial HC and 3 were on dlolesteml Iowedng medication 
(Simvaststin). Using high resolution ulbasound, we measured brachial artery 
diameter at rest, in response to reactive hyperemia (endothelium-dependent 
dilation) and to sublingual glycory~dnitrate (endothelium-independent dila- 
tion). Row mediated ilation (FMD) was assessed before and after systemic 
infusion of L-arg (0.1 g/kg body weight) and the effect compared to a 5% 
dextrose (placebo) infusion. L-alg infusion resulted in a > 20 told increase 
in serum arginine levels without change in heart rate or blood pressure in 
any subject. L-arg produced no change in baseline vessel diameter in either 
group. However FMD, which was impaired in the HC subjects, improved 
after systemic administration ofL-arg (mean FMD from 1.1 + 0.7°/= to 3 9 ± 
0.8%; p < 0.001) compared to controls in whom there was no change (mean 
FMD from 3.6 4- 0.7% to 5.2 4- 0.9%; p = NS). No changes in FMO were 
observed after the placebo infusion and all subjects had dilation to GTN (HC 
19 -4- 4.6% vs 18 4-1.5% in the conlTois). Enhanced production or decreased 
breakdown of NO may mediate the improvement inEDD which occurs in HC 
but not in normal subjects following IV administration ofLoawg. This may be 
an important anti-athemgenic strategy if it can be achieved by chronic oral 
administration with L-arg. 
i ~ ' ]  Serum Levels of Vascular Endothelial Growth 
Factor (VEGF) Are Increased in Patients W'dh 
Acute Coronary lschemia 
Robert E. Fededci, Joseph A. Puma, William A. Baker, Stsven E. Heame, 
Donald E Forttn, Linda K. Shaw, Michael H, Sketch, Richard S. Slack, 
Robert M. Calilf, Kevin G. Peters. Duke Universi~, Durham, NC 
VEGF, a potent angiogenic protein, stimulates vascular growth in response 
to ischemia. If VEGF is important in the development of coliaterol blood ves- 
sels, we hypothesized that serum %E-GP tsvels would be elevated in patients 
with acute ischemtc syndromes. To evaluate this, we pm~fy  collected 
serum samples and measured VEGF levels in 89 patients undergoing car- 
diac catheterization. Patients wifll acute isd~mic syndmme~ (group 1, n = 
41), significant CAD without s ~  o1 acute ischem~ (group 2, n = 22) 
and no significant CAO (group 3, n = 33) were compared. Baseline char- 
actedstics were similar between the groups except for a higher incidence 
of chest pain, heparin use and history of myocardial infarction and a lower 
incidence oi congestive heart ta, ure in group 1. "The ~x:luenoy of coltaterais 
by angiographic ore lab analysis was 46%, 71% and 0% in the ~ groups. 
The serum VEGF levels were 7.3, 3.9 and 5.2 ng/ml respectively. 
i 




Conc/us/on: Serum levels of VEGF are significanlfy higher in CAD pa- 
tients with acute ischemis yndromes. These findings suggest that VEGF is 
upregulated in CAD patients with acute ischemia. 
